When Tony Wood became GSK’s top scientist in mid-2022, the British pharma was waging battle.
GSK was fighting Zantac-related litigation in court while struggling to …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
According to an analysis of the UK’s cosmetic injectables industry by UCL researchers, 68% of cosmetic practitioners who are administering injections such as Botox are
Alnylam Pharmaceuticals said Monday that its treatment for an increasingly common heart condition cut the risk of death and recurrent cardiovascular complications in a key
Akantior’s commercialisation rights were acquired by Netherlands-based Avanzanite in January this year. Image credit: Shutterstock / Kateryna Kon. The European Medicines Agency’s (EMA) Committee for